UOC
PGNX

UBS O'Connor’s Progenics Pharmaceuticals Inc PGNX Stock Holding History

UBS O'Connor’s Portfolio PGNX Stock Details PGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-50,000
Closed -$204K – 541
2014
Q1 		$204K Buy
+50,000
New +$204K ﹤0.01% 389
2013
Q3 		– Sell
-318,191
Closed -$1.42M – 533
2013
Q2 		$1.42M Buy
+318,191
New +$1.42M 0.03% 337